• This topic is empty.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • #11074
    The FDA granted an Investigational New Drug, allowing the company to continue clinical trials for Ampion™ as an inhalation therapy for respiration distress due to COVID-19.
Viewing 1 post (of 1 total)
  • You must be logged in to reply to this topic.